Home
|
Contact us
|
Disclaimer
Corporate Overview
Management
Board of Directors
Contact us
Business Ethics
Product pipeline
Alzheimer's disease
Bipolar disorder
Diabetes and obesity
Inflammatory diseases
Current partnership
In/Out-licensing opportunity
Agitation/aggression in AD
Bipolar disorder
Diabetes and obesity
Cognition/function in AD
Stock quote
Financial reports
Analyst coverage
Request information
Subscribe to e-mail alert
Press release 2013
Press release archive
Webcast and presentation
MEDIA center
Press Release 2013
Press Release Archive
Webcast and Presentation
May 07, 2013
Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial Results
May 06, 2013
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. EST
Apr 30, 2013
Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401
Feb 07, 2013
Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial Results
Feb 04, 2013
Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2013 Financial Results on Thursday, February 7th, at 4:30 P.M. EST
© 2012 Transition Therapeutics Inc.
